Join the Study

    Join The Study

    start now

    Join the DAWN Alzheimer's Research Study at Join The Study.

    At DAWN Alzheimer’s Research, we’re not just studying a disease; we’re building a movement. By joining our study, you become a crucial part of a groundbreaking journey to unravel the complexities of Alzheimer’s disease. Your participation could be the key to unlocking new insights and paving the way for innovative treatments.

    Why Your Participation Matters
    • Diverse Representation: Your involvement helps ensure our research reflects the diverse genetic makeup of our community, particularly focusing on underrepresented groups.
    • Advance Scientific Understanding: Your contribution is vital in helping us understand the genetic factors of Alzheimer’s, leading to more effective treatments and preventive strategies.
    • Personal Impact: Participating in our study offers a unique opportunity to contribute to a cause that could change the future of Alzheimer’s care and prevention.
    How You Can Join
    • Eligibility: We welcome a wide range of participants, especially those from African American and Hispanic/Latino backgrounds.
    • The Process: Participation involves genetic testing, health assessments, and regular follow-ups, all conducted with the utmost respect for your privacy and comfort.
    • Support and Guidance: Our dedicated team will guide you through every step, ensuring you have all the information and support you need.

    Make a Difference Today
    Your participation in the DAWN study is more than just a contribution to research; it’s a step towards a world where Alzheimer’s is a challenge of the past. Join us in this vital mission – together, we can make a lasting impact.

    Frequently Asked Questions

    Participation in these studies will not affect your medical coverage or any other benefit received by the government.

    By participating in research studies, African Americans and Hispanic/Latinos can help scientists understand more about the genetic causes of Alzheimer’s disease and ensure that when new treatments are developed they will be able to benefit from these groundbreaking discoveries.

    There is NO cost to participate.

    Alzheimer’s disease is the most common form of dementia (severe memory loss) in the elderly. Alzheimer’s disease and other dementias affects approximately fifty-five million people worldwide with 6.7 million in the United States. Alzheimer’s disease affects parts of the brain that control memory, thinking, language and judgement.

    There is currently no cure for Alzheimer’s disease; however, there is medicine available that can temporarily reduce the symptoms. Support is also available to help someone with the condition, and their family, cope with everyday life.

    Doctors diagnose Alzheimer’s and other types of dementia based on a thorough medical history, physical examination and laboratory tests. The evaluation also includes an assessment of the characteristic changes in thinking, day-to-day function, and behavior associated with each type of change. Doctors can determine that a person has dementia with a high level of certainty.

    • Memory loss that affects daily life.
    • Challenges in planning or solving problems.
    • Difficulty doing things that were familiar to you.
    • Confusion with time or place.
    • Trouble understanding pictures and images.
    • Problems finding the right words when speaking or writing.
    • Misplacing things and losing the ability to retrace your steps.
    • Decreased or poor judgement.
    • Withdrawal from work or social activities.
    • Changes in mood and personality.

    DAWN Alzheimer’s Research focuses on understanding the genetic causes of Alzheimer’s disease in individuals of African ancestry (both in the US and Africa) and individuals of Hispanic/Latino origin to identify new preventions and treatments.

    African American, African and Hispanic/Latino individuals have not been represented in research on Alzheimer’s disease. DAWN seeks to change that and include African American, African, and Hispanic/Latino individuals in ongoing research. This will help ensure that new treatments for Alzheimer’s disease will benefit individuals from all backgrounds.

    • Individuals with a diagnosis of dementia or Alzheimer’s disease.
    • African American and Hispanic/Latino individuals over the age of 65 without memory problems.
    • Families that have 2 or more members with Alzheimer’s disease, both of whom are willing to participate in the study and any of their brothers and sisters who do not have Alzheimer’s disease and are willing to participate.
    • Individuals of any age with memory problems.
    • Individuals with a family history of Alzheimer’s disease or dementia.
    • Read and sign a consent form.
    • Give a family and medical history.
    • Answer a short environmental risk factor questionnaire.
    • Take tests of memory, thinking, mood and concentration.
    • Complete a brief neurological examination.
    • Give permission to review the medical records of the individual with memory and
      thinking problems.
    • Provide a blood sample.

    Mind Matters

    The Dawn News

    1 (877) 582-8788

    AD-HIHG@miami.edu

    Newsletter

    Subscribe to our mailing list below and we’ll keep you in the loop about our latest sales and promotions.

    © 2023 All rights reserved.

    Skip to content